CHROMATOGRAPHIC SYSTEM SUITABILITY TESTING: INFLUENCE OF CORRECTION FACTORS AND LATE ELUTING PEAKS OF IMPURITIES ON THE REQUIREMENT FOR THE SIGNAL-TO-NOISE RATIO (REVIEW)
https://doi.org/10.33380/2305-2066-2019-8-1-108-112
Abstract
Introduction. In case of methods of impurities determination quite often there are problems connected both with establishment and with check of implementation of the requirement to necessary sensitivity of a chromatographic system.
Text. Influence of correction factors and late eluting peaks of impurities on the requirement for the signal-to-noise ratio (S/N) for chromatographic system suitability testing is considered.
Conclusion. The recommendations are provided how to detect situations at which the requirement of S/N≥10 is insufficient for reliable detecting peaks of all impurities (related substances) and therewith how to correct concentration of test solution and/or the requirement to S/N for system suitability testing.
About the Author
N. A. Epshtein
Center of registration and development of medicines LLC «IRVIN 2»
Russian Federation
Russian Federation
References
1. Epshtein N. A., Emshanova S. V. Requirements to HPLC systems suitable for quality control of parent substances and dosage forms. Pharmaceutical Chemistry Journal. 2008; 42(11): 637–643.
2. Technical Guide for the Elaboration of Monographs. 7th Ed. European Pharmacopoeia. 2015.
3. United States Pharmacopoeia. USP40–NF35. 2017.
4. Russian Federation State Pharmacopoeia XIV ed. M., 2018; 2: 1004 (In Russ.).
5. Epshtein N. A. About admissible values of disregard limits for impurities and signal-to-noise ratio when checking chromatographic system sensitivity. The Bulletin of the Scientific Center for Expert Evaluation of Medicinal Products. 2017; 7(2): 85-91 (In Russ.). Available at: https://www.researchgate.net/publication/318041495_ABOUT_ADMISSIBLE_VALUES_OF_DISREGARD_LIMITS_FOR_IMPURITIES_AND_SIGNAL-TONOISE_RATIO_WHEN_CHECKING_CHROMATOGRAPHIC_SYSTEM_SENSITIVITY_O_dopustimyh_znaceniah_poroga_ignorirovania_primesej_i_otnosenia_s
6. Snyder L. R., Kirkland J. J., Glajch J. L., Practical HPLC Method Development. 3nd ed. – New Jersey: J. Wiley. 2010.
7. Reviewer Guidance: Validation of Chromatographic Methods. – Center for Drug Evaluation and Research (СDER). Washington. 1994.
8. ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology Q2(R1). – ICH. 2005.
9. Ermer Y., Miller, D. H. McB. Validation techniques in pharmaceutical analysis. Examples of best practices. – M.: VIALEK. 2013
10. Epshtein N. A. About stress experiments by developing/improving analytical methods and technology of drug substances and medicines. Drug Development & Registration. 2016; 3(16): 54–68 (In Russ.). Available at: https://www.researchgate.net/publication/309858541_ABOUT_STRESS_EXPERIMENTS_BY_DEVELOPING_IMPROVING_ANALYTICAL_METHODS_AND_TECHNOLOGY
11. Increase Waters 996 Photodiode Array Detector Sensitivity with Maxplot. Waters. 2000. Available at: http://www.waters.com/webassets/cms/library/docs/wpp06.pdf
12. HPLC Simulator 6.0. Available at: http://hplc-simulator.software.informer.com/6.0/.
13. Epshtein N. A. Compatibility between drugs and excipients when developing dosage forms. Pharmaceutical Chemistry Journal. 2018; 52(7); 50–60. Available at: http://chem.folium.ru/index.php/chem/article/view/3993.
Review
For citations:
Epshtein N.A. CHROMATOGRAPHIC SYSTEM SUITABILITY TESTING: INFLUENCE OF CORRECTION FACTORS AND LATE ELUTING PEAKS OF IMPURITIES ON THE REQUIREMENT FOR THE SIGNAL-TO-NOISE RATIO (REVIEW). Drug development & registration. 2019;8(1):108-112. (In Russ.) https://doi.org/10.33380/2305-2066-2019-8-1-108-112
Views:
1913
Email this article 